Skip to content
Reipet – Lifestyle
Author:
Applied Biologics
Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial
August 5, 2026
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
August 4, 2026
Applied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™
July 30, 2026
Applied Biologics Expands National Commercial Payer Engagement Strategy for XWRAP®
July 28, 2026
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
July 27, 2026
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
July 21, 2026
Applied Biologics Announces Submission of XWRAP® Translational Research Abstract for Consideration at SAWC Fall 2026
July 20, 2026
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
July 14, 2026
Applied Biologics Introduces ECM Preservation Technology™ as the Proprietary Manufacturing Platform Behind XWRAP®
July 9, 2026
Applied Biologics Announces VA Federal Supply Schedule Contract Modification Supporting Long-Term Access to XWRAP®
July 7, 2026
1
2
Next Page
→